Frontiers in Bioscience-Scholar,
Journal Year:
2022,
Volume and Issue:
14(2), P. 12 - 12
Published: May 6, 2022
The
COVID-19
pandemic
has
provided
an
opportunity
for
repurposing
of
drugs,
including
complex,
natural
to
meet
the
global
need
safe
and
effective
antiviral
medicines
which
do
not
promote
multidrug
resistance
nor
inflate
medical
costs.
author
herein
describes
his
own
herbal
tinctures,
previously
prepared
oncology,
into
a
possibly
synergistic,
anti-COVID
41
"herb"
formula
extracts
derived
from
36
different
plants
medicinal
mushrooms.
A
method
multi-sample
in
vitro
testing
green
monkey
kidney
vero
cells
is
proposed
Hypothesis
that
even
such
large
combination,
potency
may
be
preserved,
along
with
therapeutic
synergy,
smoothness,
complexity.
possibility
formula's
improve
age
considered,
suitable
it.
Collaborative
research
inquiries
are
welcome.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(3), P. 320 - 320
Published: Feb. 20, 2024
In
2020,
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
challenged
the
world
with
a
global
outbreak
that
led
to
millions
of
deaths
worldwide.
Coronavirus
disease
2019
(COVID-19)
is
symptomatic
manifestation
this
virus,
which
can
range
from
flu-like
symptoms
utter
clinical
complications
and
even
death.
Since
there
was
no
clear
medicine
could
tackle
infection
or
lower
its
minimal
adverse
effects
on
patients’
health,
health
organization
(WHO)
developed
awareness
programs
rate
limit
fast
spread
virus.
Although
vaccines
have
been
as
preventative
tools,
people
still
prefer
going
back
traditional
herbal
medicine,
provides
remarkable
benefits
either
prevent
viral
progression
through
different
mechanistic
pathways
relatively
insignificant
side
effects.
This
comprehensive
review
scientific
evidence
elucidating
effect
10
plants
against
SARS-CoV-2,
paving
way
for
further
studies
reconsider
plant-based
extracts,
rich
in
bioactive
compounds,
into
more
advanced
assessments
order
identify
their
impact
patients
suffering
COVID-19.
Journal of Agriculture and Food Research,
Journal Year:
2023,
Volume and Issue:
13, P. 100632 - 100632
Published: May 20, 2023
Worldwide,
Severe
acute
respiratory
syndrome
Coronavirus
(SARS-CoV-2)
pandemic
crisis,
causing
many
morbidities,
mortality,
and
devastating
impact
on
economies,
so
the
current
outbreak
of
CoV-2
is
a
major
concern
for
global
health.
The
infection
spread
quickly
caused
chaos
in
countries
around
world.
slow
discovery
limited
treatment
options
are
among
main
challenges.
Therefore,
development
drug
that
safe
effective
against
urgently
needed.
present
overview
briefly
summarizes
targets
ex:
RNA-dependent
RNA
polymerase
(RdRp),
papain-like
protease
(PLpro),
3-chymotrypsin-like
(3CLpro),
transmembrane
serine
enzymes
(TMPRSS2),
angiotensin-converting
enzyme
2
(ACE2),
structural
protein
(N,
S,
E,
M),
virulence
factors
(NSP1,
ORF7a,
NSP3c)
which
design
perspective
can
be
considered.
In
addition,
summarize
all
anti-COVID-19
medicinal
plants
phytocompounds
their
mechanisms
action
to
used
as
guide
further
studies.
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
5(1), P. 200135 - 200135
Published: March 1, 2024
Several
trials
have
been
conducted
since
the
beginning
of
COVID-19
pandemic
because
SARS-CoV-2
to
establish
possible
clinical
treatments
for
critical
COVID-19-infected
individuals.
However,
many
these
approaches
failed
demonstrate
positive
results
in
human
trials.
In
middle
this
investigation,
essential
oils
attracted
interest
due
their
numerous
benefits
and
role
management
illness.
Essential
virucidal
effects
at
nontoxic
quantities
tiny
molecular
size,
high
lipophilicity,
quick
commencement
action.
Furthermore,
pulmonary
exhalation,
lower
respiratory
tropism,
deep
lung
transport
properties
increase
potential
medicinal
usefulness.
Additionally,
popularity
as
supplementary
or
preventative
agents
is
influenced
by
low
first-pass
metabolism,
simplicity
formulation,
affordability.
To
evaluate
efficacy
oil
Following
Preferred
Reporting
Items
Systematic
Review
Meta-Analysis
(PRISMA)
guidelines,
studies
published
English
up
January
2024
were
searched
PubMed,
Scifinder,
Scopus
database,
using
relevant
keywords.
Those
non-English
articles,
abstracts,
conference
papers,
book
chapters,
reviews
excluded.
A
total
108
potentially
articles
included
full-text
review.
manuscript,
emphasize
on
scrutinizing
probable
antiviral
action
inhibit
replication
viruses
tried
provide
an
opinion
based
different
performed
same
concept
corners
world.
Various
hold
a
great
work
adjuvant
therapy
prevention
COVID-19.
Microorganisms,
Journal Year:
2023,
Volume and Issue:
11(5), P. 1308 - 1308
Published: May 17, 2023
In
the
wake
of
COVID-19
crisis,
a
need
has
arisen
to
prevent
and
treat
two
related
conditions,
vaccine
injury
long
COVID-19,
both
which
can
trace
at
least
part
their
aetiology
spike
protein,
cause
harm
through
several
mechanisms.
One
significant
mechanism
is
vascular,
it
mediated
by
common
element
illness,
receiving
vaccine.
Given
number
people
experiencing
these
imperative
develop
treatment
protocols,
as
well
consider
diversity
injury.
This
review
summarizes
known
options
for
injury,
mechanisms,
evidentiary
basis.
Heliyon,
Journal Year:
2023,
Volume and Issue:
10(1), P. e22918 - e22918
Published: Dec. 3, 2023
This
study
used
probiotics
and
micro-encapsulated
clove
cinnamon
oils
to
develop
a
functional
cream-stuffed
cake
based
on
sweet
potatoes
flour
rice
instead
of
wheat
flour.
The
was
evaluated
for
its
physical,
chemical,
sensory
properties
antioxidant
capacity.
protective
effect
the
against
liver
injury
immunosuppression
induced
by
thioacetamide
injection
in
male
rats
also
evaluated.
found
that
eugenol
cinnamaldehyde
were
majority
volatile
compounds
essential
cake,
with
values
78.73
%
81.57
%,
respectively,
as
determined
GC-MS
analysis.
viable
counts
added
ranged
from
13.15
11.21
log
CFU/g
still
above
threshold
health
benefits.
had
an
increased
dietary
fiber
protein
content
while
containing
low-fat
percentage
compared
commercial
sample.
innovative
contained
higher
levels
water-soluble
fat-soluble
vitamins
minerals
such
iron,
calcium,
potassium,
zinc.
capacity
evaluated,
it
contain
1827.23
mg
GAE/100
g
total
phenols
97.13
QE/100
flavonoids.
have
activity
effective
protecting
oxidative
stress
inflammation
reducing
immunodeficiency
associated
damage.
Phytochemical Analysis,
Journal Year:
2024,
Volume and Issue:
35(4), P. 664 - 677
Published: Jan. 15, 2024
Abstract
Introduction
The
COVID‐19
pandemic
was
associated
with
an
increased
global
use
of
traditional
medicines,
including
Ayurvedic
herbal
preparations.
Due
to
their
growing
demand,
processed
nature,
and
the
complexity
supply
chain,
there
is
risk
adulteration
in
these
products.
Objectives
objective
this
study
assess
DNA
barcoding
for
species
identification
supplements
on
US
market
treatment
respiratory
symptoms.
Methods
A
total
54
commercial
products
containing
herbs
were
tested
four
regions
(i.e.,
rbcL
,
matK
ITS2,
mini‐ITS2)
using
two
composite
samples
per
product.
Nine
categories
targeted:
amla,
ashwagandha,
cinnamon,
ginger,
guduchi,
tribulus,
tulsi,
turmeric,
vacha.
Results
At
least
one
identified
64.8%
expected
detected
38.9%
Undeclared
plant
species,
other
herbs,
rice,
pepper,
19
products,
fungal
12
presence
undeclared
may
be
a
result
intentional
substitution
or
contamination
during
harvest
processing,
while
likely
material
environment.
greatest
sequencing
success
(42.6–46.3%)
obtained
primers.
Conclusion
results
indicate
that
combination
genetic
loci
should
used
supplements.
limitations
future
research
incorporate
chemical
characterization
techniques.
Current Therapeutic Research,
Journal Year:
2023,
Volume and Issue:
98, P. 100699 - 100699
Published: Jan. 1, 2023
Herbal
medicines
have
been
extensively
used
to
treat
coronavirus
disease
2019
(COVID-19).
Garlic,
known
exert
antiviral
and
anti-inflammatory
effects,
can
be
coadministered
with
standard
treatments
combat
COVID-19.The
aim
of
the
study
was
evaluate
efficacy
safety
profile
Gallecina
oral
capsules
(Samisaz
Pharmaceutical
Company,
Mashhad,
Iran),
a
fortified
garlic
extract,
as
adjunctive
therapy
improve
clinical
status
symptoms
in
noncritically
ill
patients
hospitalized
for
COVID-19.This
triple-blind
randomized,
placebo-controlled
trial
conducted
on
COVID-19
nonintensive
care
wards
Imam
Hassan
Hospital.
Patients
received
remdesivir
plus
90
mg
capsule
or
placebo
every
8
hours
5
days
until
discharge.
The
status,
respiratory
symptoms,
laboratory
parameters
were
recorded
during
period.Patients
enrolled
between
April
24
July
18,
2021.
Data
from
72
group
69
analyzed.
Oxygen
saturation,
C-reactive
protein
levels,
distribution
distress
cough
similar
groups
day
Although
body
temperature
significantly
lower
than
that
discharge
(P
=
0.04),
it
within
normal
range
both
groups.
proportion
requiring
supplemental
oxygen
at
least
1
reduced
3
4
<
0.05).
Gastrointestinal
complaints
more
prevalent
but
difference
not
statistically
significant
0.12).There
no
effect
primary
outcome
6.
Gallecina-treated
who
needed
decreased
discharge,
there
other
days.
possible
beneficial
effects
requirements
may
warrant
further
investigation.
(Curr
Ther
Res
Clin
Exp.
2023;
84:XXX-XXX).
Clinical
registration:
IRCT20201111049347N1.